Neurocrine Biosciences (NBIX) 📈: отчетность и дивиденды за 2025

Reports

IFRS

Reporting Annual Quarterly

	2016	2017	2018	2019	2020	2021	2022	2023
Financial report	link	link	link	link	link	link	link	link

	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2
Financial report	link	link	link	link	link	link	link	link	link	link

Capitalization

IFRS

Reporting Annual Quarterly

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	LTM	Average for 5 years	CAGR 5
Capitalization, bln $	1.88	4.92	3.41	7.37	6.78	8.92	7.93	11.44	10.8		10.44	9.17	9.76
Revenue, bln $		0.015	0.162	0.4512	0.7881	1.05	1.13	1.49	1.89	2.36	2.36	1.58	17.58
Net profit, bln $		-0.141	-0.143	0.0211	0.037	0.4073	0.0896	0.1545	0.2497	0.3413	0.3413	0.2485	-3.47
EV, bln $		3.05	3.26	7.28	10.89	8.8	8.39	12.07	13.15	14.44	14.44	11.37	10.41
EBIT, bln $		-0.1551	-0.1338	0.0524	0.2191	0.3189	0.1969	0.249	0.3367	0.6126	0.6126	0.3428	13.95
EBITDA, bln $		-0.1459	-0.129	0.0564	0.2266	0.3275	0.2078	0.2646	0.358	0.6397	0.6397	0.3595	14.33
OIBDA $						0.2477	0.326	0.3591	0.3592	0.8689	0.8689	0.4322	28.53
Book value, bln $		-1.06	-1.2	0.4808	0.6369	1.13	1.37	1.71	2.23	2.59	2.59	1.81	18.04
FCF, bln $		-0.11	-0.101	0.0766	0.1373	0.2176	0.2331	0.3229	0.3616	0.5572	0.5572	0.3385	20.69
Operating Cash Flow, bln $		-0.1062	-0.0943	0.1014	0.1521	0.2285	0.2565	0.3394	0.3899	0.5954	0.5954	0.3619	21.11
Operating profit, bln $		-0.147	-0.131	0.0369	0.2191	0.3189	0.1969	0.249	0.2509	0.5705	0.5705	0.3172	12.34
Operating expenses, bln $		0.1624	0.2917	0.4095	0.5541	0.7083	0.9114	1.22	1.6	1.75	1.75	1.24	19.83
CAPEX, bln $		0.004	0.007	0.0248	0.0147	0.0109	0.0234	0.0165	0.0283	0.0382	0.0382	0.0235	28.51

	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	Average for 5 quarters	CAGR 5
Capitalization, bln $	8.93	9.32	10.18	11.5	9.83	9.2	11.01	0	13.76	0			11.06	3.65
Revenue, bln $			0.3879	0.412	0.4204	0.4527	0.4988	0.5152	0.5153	0.5902	0.6221	0.6277	0.5741	4.03
Net profit, bln $			0.0685	0.089	-0.0766	0.0955	0.0831	0.1477	0.0434	0.065	0.1298	0.1031	0.0978	-6.94
EV, bln $			10.09	12.16	9.77	9.73	11.34	13.32	14.44	14.04	11.92	14.33	13.61	1.47
EBIT, bln $			0.0878	0.1302	-0.1142	0.0735	0.1357	0.1503	0.1053	0.1479	0.1848	0.1626	0.1502	1.59
EBITDA, bln $			0.0918	0.1034	0.0297	0.0736	0.1412	0.156	0.1115	0.1552	0.1913	0.1697	0.1567	1.70
OIBDA $								0.1586	0.1734	0.2381	0.2453	0.2086	0.2048	5.63
Book value, bln $			1.54	1.71	1.68	1.85	2	2.23	2.39	2.51	2.72	2.59	2.49	3.04
FCF, bln $			0.0988	0.1412	-0.1337	0.1728	0.2044	0.1181	0.1191	0.053	0.1499	0.2352	0.1351	14.77
Operating Cash Flow, bln $			0.0988	0.143	-0.1252	0.1796	0.212	0.1235	0.1303	0.0646	0.158	0.2425	0.1438	14.45
Operating profit, bln $			0.0878	0.1034	-0.1142	0.0736	0.1412	0.1503	0.1053	0.1479	0.1838	0.142	0.1459	-1.13
Operating expenses, bln $			0.294	0.3009	0.3822	0.3676	0.3464	0.3564	0.3972	0.4267	0.4303	0.4764	0.4174	5.98
CAPEX, bln $			0.0017	0.0018	0.0085	0.0068	0.0076	0.0054	0.0112	0.0116	0.0081	0.0073	0.0087	6.21

	Average for 5 quarters	CAGR 5

Cash flow Cash flow quarterly Assets

Balance sheet

IFRS

Reporting Annual Quarterly

	2003	2004	2005	2006	2007	2010	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	LTM	Average for 5 years	CAGR 5
Cash, bln $										0.0833	0.5159	0.1417	0.1123	0.801	0.3408	0.2629	0.2511	0.233	0.233	0.3778	-21.88
Short-Term Investments $										0.2241	0.2612	0.5092	0.5582	0.6139	0.3705	0.7264	0.7805	0.8431	0.8431	0.6669	6.55
Long-Term Investments $								0.0375	0.0825	0.0435	0.2474	0.216	0.2997	0.2271	0.5607	0.4015	0.8494			0.4677	23.16
Accounts Receivable $							0.0000				0.0311	0.0562	0.1266	0.1571	0.1855	0.35	0.4393	0.4791	0.4791	0.3222	24.98
Total Current Assets $										0.3104	0.5549	0.7378	0.831	1.02	0.9728	1.45	1.61	1.72	1.72	1.35	11.02
Net assets, bln $									0.4245	0.3149	0.3721	0.7378	0.831	1.02	0.9728	0.0586	1.43		0.0586	0.8625	11.47
Assets, bln $										0.3651	0.8176	0.9932	1.31	1.73	2.07	2.37	3.25	3.72	3.72	2.63	16.55
Short-Term Debt $									0.0125	0.0149	0.0384	0.0882	0.4088	0.094	0.225	0.1694	0.1701		0.1701	0.2135	-16.09
Long-Term Debt $	0.0325	0.0595	0.0536	0.0492	0.1087						0.3696	0.3885	0.4088	0.3179	0.3351					0.3640	-1.94
Liabilities, bln $										0.0502	0.4455	0.5124	0.6691	0.6085	0.6985	0.6609	1.02	1.13	1.13	0.8236	13.18
Net debt, bln $										-0.0833	0.4845	0.756	0.3832	-0.3887	0.0996	0.1694	0.1773	0.2221	0.2221	0.0559	-189.41
Debt, bln $										0	0.3696	0.8977	0.4955	0.4123	0.4404	0.2629	0.4284	0.4551	0.4551	0.3998	1.99
Interest Income $									0.0019	0.0028	0.0133	0.0151	0.0257							0.0118	68.36
Interest Expense, bln $						0.007					0.0195	0.0305	0.032	0.0328	0.0258	0.0071	0.0046	0.1266	0.1266	0.0394	31.01
Net interest income, bln $										0.0028	0.0133	0.0151	0.0257	-0.0328	-0.0258	-0.0071	-0.0046			-0.0089	-170.89
Goodwill $																0.0054	0.0058			0.0056	3.64
Amortization, bln $										0.0015	0.0024	0.004	0.0075	0.0086	0.0109	0.0156	0.0213	0.0271	0.0271	0.0167	25.80
Cost of production, bln $										0	0.0013	0.0049	0.0074	0.0101	0.0143	0.0232	0.0397	0.034	0.034	0.0243	27.48
Inventory $							0.0000				-0.0311	0.0109	0.0173	0.028	0.0305	0.0351	0.0383	0.0574	0.0574	0.0379	15.44

	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	Average for 5 quarters	CAGR 5
Cash, bln $													0.2122	0.2629	-0.0904	0.1602	0.2937	0.2511	0.3963	0.1397	0.3491	0.233	0.2738	-1.49
Short-Term Investments $													0.5872	0.7264	1.14	0.8165	0.8014	0.7805	0.8143	0.8992	0.8789	0.8431	0.8432	1.55
Long-Term Investments $									0.549	0.5607	0.541	0.4052	0.4575	0.4015	0.3803	0.3426	0.5875	0.8494					0.5123	16.17
Accounts Receivable $													0.3012	0.35	0.3916	0.3876	0.4178	0.4393	0.4507	0.4682	0.4811	0.4791	0.4637	1.75
Total Current Assets $													1.21	1.45	1.43	1.5	1.65	1.61	1.8	1.67	1.88	1.72	1.74	1.33
Net assets, bln $											1.02	1.02	1.21	1.45	0.0628	0.0656	2	2.23	2.39	2.51			1.84	107.28
Assets, bln $													2.14	2.37	2.36	2.61	2.85	3.25	3.47	3.31	3.54	3.72	3.46	2.74
Short-Term Debt $												0.0171	0.1692	0.1694	0.0184	0.1697	0.1699	0.2021	0.1578	0.0354	0.0348		0.1200	-27.18
Long-Term Debt $				0.4088	0.4141	0.3179	0.322	0.3263	0.3307	0.3351	0.3777	0.169			0.1695								0.2764	-12.51
Liabilities, bln $													0.5988	0.6609	0.6753	0.7601	0.8461	1.02	1.09	0.7958	0.8161	1.13	0.9704	2.07
Net debt, bln $													0.0536	0.1694	0.3503	0.0986	-0.0379	0.1773	0.1506	0.1519	-0.0977	0.2221	0.1208	4.61
Debt, bln $													0.2658	0.2629	0.2599	0.2588	0.2558	0.4284	0.5469	0.2916	0.2514	0.4551	0.3947	1.22
Interest Income $	0.0016	0.0176	0.0317	0.0101	0.02																		0.0162	65.72
Interest Expense, bln $											0.0026	0.0022	0.0012	0.0011	0.0011	0.0013	0.0011	0.0011	0.0011	0.0497			0.0109	107.24
Net interest income, bln $									-0.0066	-0.0066	-0.0026	-0.0022	-0.0012	-0.0011	-0.0011	-0.0013	-0.0011	-0.0011					-0.0011	0.00
Goodwill $														0.0054				0.0058					0.0056	3.64
Amortization, bln $													0.004	0.0044	0.1439	0.000122	0.0055	0.0057	0.0062	0.0073	0.0065	0.0071	0.0066	4.49
Cost of production, bln $													0.0061	0.0077	0.0085	0.0115	0.0112	0.0085	0.0128	0.0156	0.008	0.0093	0.0108	1.82
Inventory $													0.037	0.0351	0.0334	0.0317	0.0288	0.0383	0.0372	0.0425	0.0458	0.0574	0.0442	8.43

Share

IFRS

Reporting Annual Quarterly

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	LTM	Average for 5 years	CAGR 5
EPS	-1.63	-1.62	0.2213	0.3866	4.16	0.9152	1.56	2.47	3.29		3.29	2.48	-4.58
Share price		38.7	77.59	71.41	107.49	95.85	102.4	131.76	136.5	125.01	125.01	118.30	5.46
Number of shares, mln	87	88	95	95	97	97	98.9	101	103.7		103.7	99.52	1.34
FCF/share	-1.27	-1.15	0.8025	1.43	2.22	2.38	3.26	3.58	5.37		5.37	3.36	19.32

	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	Average for 5 quarters	CAGR 5
EPS					0.6919	0.8829	-0.7889	0.9531	0.822	1.44	0.4189	0.6256	1.24	1			0.9449	-7.03
Share price			84.75	92.29	101.46	117.13	104.06	97.71	105.3	115.11					116.18	125.01	111.86	5.05
Number of shares, mln	97.7	94.9	97.6	95.6	99	100.8	97.1	100.2	101.1	102.3							100.30	0.30
FCF/share					0.998	1.4	-1.38	1.72	2.02	1.15	1.15	0.5101	1.44	2.29			1.31	14.77

Efficiency

IFRS

Reporting Annual Quarterly

	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	LTM	Industry average	Average for 5 years	CAGR 5
ROE, %						-38.17	-41.5	4.95	6.62	46.2	7.17	10.03	12.68	14.16		14.16	17.60	18.05	-21.06
ROA, %						-33.6	-24.11	2.33	3.22	26.79	4.71	6.96	8.89	9.79		9.79	5.71	11.43	-18.24
ROIC, %			-33.84	-37.17	-28.7	-38.93	-17.25	6.28	5.18	38.13	6.7					5.01	17.65	7.81	-182.77
ROS, %							-81.27	11.61	9.96	13.34	11.22	10.38	13.23	14.49	14.49	14.49	13.36	12.76	5.25
ROCE, %							-35.95	5.79	29.59	20.6	10.78	13.6	12.97	19.08	23.66	23.66	29.73	16.02	17.03
EBIT margin									27.81	30.49	17.37	16.73	17.84	26.01	26.01	26.01	18.53	20.79	8.41
EBITDA margin							-79.79	12.5	28.75	31.31	18.33	17.77	18.97	27.16	27.16	27.16	26.10	21.88	8.18
Net margin						-982.5	-81.3	4.68	4.69	38.94	7.9	10.38	13.23	14.49		14.49	13.36	16.99	-17.94
Operational efficiency, %							-81.27	8.18	28.75	31.31	9.04	16.73	13.3	24.22	24.22	24.22	16.64	17.50	21.79
Net interest margin, %	48.53	9.46			-449.84	-940.6	-88.19	4.68	4.7	38.94	7.9					5.91	24.17	-6.3940	-161.72
FCF yield, %				-6.96	-2.13	-2.24	-2.97	0.8342	1.55	2.13	2.54	3.24	3.35					2.56	16.67

	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q2	2025Q3	Industry average	Average for 5 quarters	CAGR 5
ROE, %			4.86	6.03	-4.93	5.15	4.74	7.87	2.14	2.95	5.47	4.11			17.60	4.51	-12.18
ROA, %			3.3	3.94	-3.24	3.65	3.04	4.84	1.29	1.92	3.8	2.84			5.71	2.94	-10.11
ROS, %					-18.22	21.1	16.66	28.67	8.42	11.01	20.86	16.43	14.49	14.49	13.36	15.46	5.65
ROCE, %					-6.35	3.97	6.78	6.86	4.41	5.68	6.5	5.43	23.66	23.66	29.73	12.99	33.03
EBIT margin							27.21	29.17	20.43	25.06	29.71	25.9	26.01	26.01	18.53	26.54	0.75
EBITDA margin					7.06	16.26	28.31	30.28	21.64	26.3	30.75	27.04	27.16	27.16	26.10	27.68	0.65
Net margin			17.66	21.6	-18.22	21.1	16.66	28.67	8.42	11.01	20.86	16.43			13.36	17.08	-10.54
Operational efficiency, %					-27.16	16.26	28.31	29.17	20.43	25.06	29.55	22.62	24.22	24.22	16.64	25.13	-0.68
FCF yield, %	1.14	1.42	1.74	2.79	2.4	3.03	1.64	2.68	4.46	3.56						3.07	3.28

	Industry average	Average for 5 quarters	CAGR 5

Coefficients

IFRS

Reporting Annual Quarterly

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	LTM	Industry average	Average for 5 years	CAGR 5
P/E	-34.71	-23.89	309.19	283.94	22.57	92.58	77.01	51.96	41.64		41.64	69.12	57.15	13.03
P/BV	9.6	19.8	13.58	16.5	8.16	6.04	6.97	5.81	5.49		5.49	8.87	6.49	-7.62
P/S	222.2	101	14.47	13.33	8.79	7.32	7.99	6.87	6.03		6.03	8.05	7.40	-7.26
P/FCF		-74.85	91.14	76.48	43.04	34.89	30.91	32.33	28.87	18.74	18.74	8.97	29.15	-11.69
E/P		-0.029	0.0023	0.0042	0.0398	0.0098	0.0155	0.0231	0.0239	0.0327	0.0327	0.03	0.0210	27.25
EV/EBIT				49.7	28.18	42.85	48.47	39.06	23.56	23.56	23.56	88.11	35.50	-11.28
EV/EBITDA	-26.48	-30.17	129.15	48.05	26.88	40.4	45.61	36.73	22.57		22.57	53.63	34.44	-3.43
EV/S		31.4	21.02	12.13	9.32	8.11	8.11	6.97	6.13	6.13	6.13	8.36	7.09	-5.44
EV/FCF		-50.12	123.92	69.61	44.82	39.41	37.37	36.37	25.91	25.91	25.91	21.77	32.99	-8.05
Debt/EBITDA		-5.73	15.92	2.19	1.26	2.12	0.9936	1.2	0.7114	0.7114	0.7114	2.61	1.15	-19.62
Netdebt/Ebitda		-3.46	12.95	13.06	1.95	1.95	0.6402	0.4953	0.3472	0.3472	0.3472	0.49	0.7560	-29.19
Debt/Ratio		0.54	0.52	0.51	0.35	0.34	0.111	0.1318	0.1224	0.1224	0.1224	0.24	0.1655	-18.48
Debt/Equity		1.2	1.07	1.05	0.54	0.51	0.1539	0.1919	0.1757	0.436	0.436	2.82	0.2935	-3.09
Debt/Net Income		-2.86	21.36	22.1	0.8058	3.92	1.7	1.72	1.33	1.33	1.33	10.75	2.00	-19.44
PEG										-41.35	-41.35	-67.37	-41.3500	0.00
Beta					0.84	0.76	0.48	1.39	-2.04	0.3408	0.3408	-0.03	0.1862	-14.82
Altman Index		8.56	7.92	9.25	10.09	3.55	5.73	6.26	4.97	4.59	4.59	12.59	5.02	5.27

	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	Industry average	Average for 5 quarters	CAGR 5
P/E				174.57	77.2	153.6	55.25	60.19	52.86	37.91	40.37	30.87	41.65				69.12	40.73	-4.66
P/BV				6.5	7.02	5.59	5.2	5.68	5.89	5.99	5.53	4.42	5.45				8.87	5.46	-1.54
P/S				7.07	7.85	5.96	5.7	6.3	6.83	7.09	6.48	5.32	6.03				8.05	6.35	-2.46
P/FCF		-171.97	68.24	99.95	83.62	-75.57	56.66	52.08	99.71						18.74	18.74	8.97	49.19	-19.85
E/P		0.0017	-0.0019	0.0068	0.0075	-0.0076	0.0098	0.0078	0.0125						0.0327	0.0327	0.03	0.0191	27.25
EV/EBIT								83.54	88.61	137.12	94.9	64.5	88.1		23.56	23.56	88.11	58.92	-24.32
EV/EBITDA				66.11	46.72	34.48	132.16	32.58	46.86	29.29	24.65	19.41	22.82				53.63	28.61	-13.40
EV/S						24.7	21.49	22.73	25.85	28.02	23.78	19.16	22.82		6.13	6.13	8.36	15.60	-23.75
EV/FCF						-77.66	56.29	55.46	112.77	121.24	264.81	79.52	60.91		25.91	25.91	21.77	91.41	-37.18
Debt/EBITDA						8.75	3.52	1.81	2.75	4.9	1.88	1.31	2.68		0.7114	0.7114	2.61	1.46	-17.66
Netdebt/Ebitda						11.79	1.34	-0.2684	1.14	1.35	0.9787	-0.5107	1.31		0.3472	0.3472	0.49	0.4945	-18.72
Debt/Ratio						0.0796	0.099	0.0898	0.1318	0.1575	0.0882	0.0711	0.1224		0.1224	0.1224	0.24	0.1053	6.77
Debt/Equity						0.1115	0.1397	0.1278	0.1919	0.2292	0.1162	0.0925	0.1757		0.436	0.436	2.82	0.2513	30.27
Debt/Net Income						-2.45	2.71	3.08	2.9	12.6	4.49	1.94	4.41		1.33	1.33	10.75	2.70	-21.60
PEG															-41.35	-41.35	-67.37	-41.3500	0.00
Beta														1.13	0.9934	0.3408	-0.03	0.8214	-32.94
Altman Index	5.55	4.97	5.93	6.67	6.56	5.42	5.21							4.97	4.59	4.59	12.59	4.96	-3.27

Dividends

IFRS

Reporting Annual Quarterly

	2015	2016	2017	2018	2019	2020	2021	2022	2023	LTM	Industry average	Average for 5 years	CAGR 5
Dividend										0
Dividend yield, %	0	0	0	0	0	0	0	0	0	0	1.71
Dividends / profit, %						0	0	0		0	155.02

	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	Industry average	Average for 5 quarters	CAGR 5
Dividends / profit, %	0	0	0	0	0	0	0	0	0	0	155.02

	Industry average	Average for 5 quarters	CAGR 5

Other

IFRS

Reporting Annual Quarterly

	2016	2017	2018	2019	2020	2021	2022	2023	2024	LTM	CAGR 5
R&D, bln	0.0943	0.1218	0.1605	0.2	0.275	0.3281	0.4638	0.565		0.4638	23.08
Total Debt			0.0882	0.5653	0.1865						28.35
CAPEX/Revenue, %					1.04	2.06	1.11	1.5	1.62	1.62	9.27
Staff, people						865	900	1 200	1 400		12.79

	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	CAGR 5
R&D, bln	0.1022	0.1359	0.1077	0.118	0.1395	0.1458	0.1422	0.1375	0.1594	0.1911			5.56
CAPEX/Revenue, %								1.05	2.17	1.97	1.3	1.16	2.01

	CAGR 5

Investing Port

Neurocrine Biosciences

Reporting Neurocrine Biosciences

Reports

Capitalization

Balance sheet

Share

Efficiency

Coefficients

Dividends

Pay for your subscription

Other